IQVIA Holdings Inc
(LTS:0JDM)
$
213.2157
-4.2843 (-1.97%)
Market Cap: 38.98 Bil
Enterprise Value: 51.15 Bil
PE Ratio: 29.71
PB Ratio: 6.25
GF Score: 90/100 - Q1 2024 IQVIA Holdings Inc Earnings Call TranscriptMay 02, 2024$224.44 (-3.19%)Earnings
- IQVIA Holdings Inc at Citigroup Inc Unplugged Medtech and Life Sciences Access Day TranscriptFeb 29, 2024
- Q4 2023 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2024$238.36 (+11.09%)Earnings
- IQVIA Holdings Inc at Evercore ISI HealthCONx Conference TranscriptNov 29, 2023
- Q3 2023 IQVIA Holdings Inc Earnings Call TranscriptNov 01, 2023$178.53 (-1.13%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 13, 2023
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2023
- Q2 2023 IQVIA Holdings Inc Earnings Call TranscriptAug 01, 2023$220.68 (-1.55%)Earnings
- IQVIA Holdings Inc. - Special Call TranscriptMay 24, 2023
- Q1 2023 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2023$179.91 (-6.14%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 15, 2023
- Q4 2022 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2023$225.68 (-4.18%)Earnings
- IQVIA Holdings Inc Corporate Call TranscriptJan 18, 2023
- IQVIA Holdings Inc at Credit Suisse Healthcare Conference TranscriptNov 08, 2022
- Q3 2022 IQVIA Holdings Inc Earnings Call TranscriptOct 26, 2022$202.9 (+4.31%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 14, 2022
- IQVIA Holdings Inc at Morgan Stanley Global Healthcare Conference TranscriptSep 13, 2022
- Q2 2022 IQVIA Holdings Inc Earnings Call TranscriptJul 21, 2022$219 (+1.18%)Earnings
- IQVIA Holdings Inc at Jefferies Healthcare Conference TranscriptJun 10, 2022
- IQVIA Holdings Inc. - Special Call TranscriptMay 04, 2022
- Q1 2022 IQVIA Holdings Inc Earnings Call TranscriptApr 27, 2022$214.25 (+4.21%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 16, 2022
- IQVIA Holdings Inc at Citi Healthcare Conference (Virtual) TranscriptFeb 24, 2022
- Q4 2021 IQVIA Holdings Inc Earnings Call TranscriptFeb 15, 2022$226.7 (-5.02%)Earnings
- IQVIA Holdings Inc Analyst and Investor Conference (Virtual) TranscriptNov 16, 2021
- Q3 2021 IQVIA Holdings Inc Earnings Call TranscriptOct 21, 2021$243.5 (-3.62%)Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference (Virtual) TranscriptSep 14, 2021
- Q2 2021 IQVIA Holdings Inc Earnings Call TranscriptJul 27, 2021$249.18Earnings
- IQVIA Holdings Inc at William Blair Growth Stock Conference (Virtual) TranscriptJun 02, 2021
- Q1 2021 IQVIA Holdings Inc Earnings Call TranscriptApr 22, 2021$225.56 (+4.18%)Earnings
- IQVIA Holdings Inc at Barclays Global Healthcare Conference (Virtual) TranscriptMar 09, 2021
- Q4 2020 IQVIA Holdings Inc Earnings Call TranscriptFeb 10, 2021$193.54 (+3.80%)Earnings
- Q3 2020 IQVIA Holdings Inc Earnings Call TranscriptOct 20, 2020$163.56Earnings
- Q2 2020 IQVIA Holdings Inc Earnings Call TranscriptJul 22, 2020$160 (+1.43%)Earnings
- Q1 2020 IQVIA Holdings Inc Earnings Call TranscriptApr 28, 2020$131.64Earnings
- Q4 2019 IQVIA Holdings Inc Earnings Call TranscriptFeb 12, 2020$159.76Earnings
- Q3 2019 IQVIA Holdings Inc Earnings Call TranscriptOct 30, 2019$147.45Earnings
- IQVIA Holdings Inc at Robert W Baird Global Healthcare Conference TranscriptSep 04, 2019
- Q2 2019 IQVIA Holdings Inc Earnings Call TranscriptJul 24, 2019$156.08Earnings
- IQVIA Holdings Inc Analyst and Investor Conference TranscriptJun 18, 2019
- IQVIA Holdings Inc at William Blair Growth Stock Conference TranscriptJun 05, 2019
- Q1 2019 IQVIA Holdings Inc Earnings Call TranscriptMay 01, 2019$137.38Earnings
- IQVIA Holdings Inc at Alliance for Regenerative Medicine Cell & Gene Meeting on the Mediterranean TranscriptApr 23, 2019
- IQVIA Holdings Inc at Barclays Global Healthcare Conference TranscriptMar 12, 2019
- Q4 2018 IQVIA Holdings Inc Earnings Call TranscriptFeb 14, 2019$131.66Earnings
IQVIA Holdings Inc at Credit Suisse Healthcare Conference Transcript
Nov 08, 2022 / 05:10PM GMT
Release Date Price:
$207.59
(+1.62%)
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
All right. With that, we'll kick things off. Thank you, everybody, for joining us. Next session is IQVIA. We're happy to have with us Ron Bruehlman, CFO. I'm Dan Leonard. I cover life science tools and services for Credit Suisse. And we'll kick things straight off. Ron, welcome.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Thank you.
Questions & Answers
Daniel Louis Leonard;dit Suisse AG
CrÃ;Research Division - Research Analyst
© -
So you just closed up your Q3 -- reported Q3 earnings. Figured a good way to start off would be to remind us of the key highlights and takeaways from the Q3 report.
Ronald E. Bruehlman
IQVIA Holdings Inc. - Executive VP & CFO
Sure. Well, look, I think the #1 highlight, Dan, is that the market remains very strong for us. I know there's been concern, particularly about the emerging
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)